-
3
-
-
0026503028
-
Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience
-
Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10: 5-15, 1992.
-
(1992)
J Clin Oncol
, vol.10
, pp. 5-15
-
-
Meyers, P.A.1
Heller, G.2
Healey, J.3
-
4
-
-
0038343499
-
MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
-
Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676, 2003.
-
(2003)
Cell
, vol.113
, pp. 673-676
-
-
Ambros, V.1
-
5
-
-
58249088751
-
MicroRNAs: Target recognition and regulatory functions
-
Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
-
(2009)
Cell
, vol.136
, pp. 215-233
-
-
Bartel, D.P.1
-
6
-
-
0037418839
-
Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila
-
Brennecke J, Hipfner DR, Stark A, Russell RB and Cohen SM: bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36, 2003.
-
(2003)
Cell
, vol.113
, pp. 25-36
-
-
Brennecke, J.1
Hipfner, D.R.2
Stark, A.3
Russell, R.B.4
Cohen, S.M.5
-
7
-
-
0034708122
-
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
-
Reinhart BJ, Slack FJ, Basson M, et al: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906, 2000.
-
(2000)
Nature
, vol.403
, pp. 901-906
-
-
Reinhart, B.J.1
Slack, F.J.2
Basson, M.3
-
9
-
-
77958569998
-
Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: From functions to targets
-
Wang D, Qiu C, Zhang H, Wang J, Cui Q and Yin Y: Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One 5: e13067, 2010.
-
(2010)
PLoS One
, vol.5
-
-
Wang, D.1
Qiu, C.2
Zhang, H.3
Wang, J.4
Cui, Q.5
Yin, Y.6
-
11
-
-
27244432205
-
MicroRNAs as oncogenes and tumor suppressors
-
Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
-
(2005)
N Engl J Med
, vol.353
, pp. 1768-1771
-
-
Chen, C.Z.1
-
12
-
-
60149084560
-
MicroRNAs and cancer: Short RNAs go a long way
-
Ventura A and Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591, 2009.
-
(2009)
Cell
, vol.136
, pp. 586-591
-
-
Ventura, A.1
Jacks, T.2
-
14
-
-
84878404863
-
MicroRNAs in osteosarcoma: From biological players to clinical contributors, a review
-
Zhou G, Shi X, Zhang J, Wu S and Zhao J: MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review. J Int Med Res 41: 1-12, 2013.
-
(2013)
J Int Med Res
, vol.41
, pp. 1-12
-
-
Zhou, G.1
Shi, X.2
Zhang, J.3
Wu, S.4
Zhao, J.5
-
15
-
-
84880320805
-
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling
-
Li Y, Zhang J, Zhang L, Si M, Yin H and Li J: Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis 34: 1601-1610, 2013.
-
(2013)
Carcinogenesis
, vol.34
, pp. 1601-1610
-
-
Li, Y.1
Zhang, J.2
Zhang, L.3
Si, M.4
Yin, H.5
Li, J.6
-
16
-
-
41749113108
-
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
-
Asangani IA, Rasheed SA, Nikolova DA, et al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
-
(2008)
Oncogene
, vol.27
, pp. 2128-2136
-
-
Asangani, I.A.1
Rasheed, S.A.2
Nikolova, D.A.3
-
17
-
-
34547524771
-
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
-
Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007.
-
(2007)
Gastroenterology
, vol.133
, pp. 647-658
-
-
Meng, F.1
Henson, R.2
Wehbe-Janek, H.3
Ghoshal, K.4
Jacob, S.T.5
Patel, T.6
-
18
-
-
84655165083
-
MicroRNA-21 is involved in osteosarcoma cell invasion and migration
-
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun L: MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 28: 1469-1474, 2011.
-
(2011)
Med Oncol
, vol.28
, pp. 1469-1474
-
-
Ziyan, W.1
Shuhua, Y.2
Xiufang, W.3
Xiaoyun, L.4
-
19
-
-
84863719696
-
MicroRNA cloning and sequencing in osteosarcoma cell lines: Differential role of miR-93
-
Montanini L, Lasagna L, Barili V, et al: MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93. Cell Oncol (Dordr) 35: 29-41, 2012.
-
(2012)
Cell Oncol (Dordr)
, vol.35
, pp. 29-41
-
-
Montanini, L.1
Lasagna, L.2
Barili, V.3
-
20
-
-
84863121672
-
miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression
-
Huang G, Nishimoto K, Zhou Z, Hughes D and Kleinerman ES: miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 72: 908-916, 2012.
-
(2012)
Cancer Res
, vol.72
, pp. 908-916
-
-
Huang, G.1
Nishimoto, K.2
Zhou, Z.3
Hughes, D.4
Kleinerman, E.S.5
-
21
-
-
80051587553
-
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration
-
Duan Z, Choy E, Harmon D, et al: MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 10: 1337-1345, 2011.
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 1337-1345
-
-
Duan, Z.1
Choy, E.2
Harmon, D.3
-
22
-
-
83055163471
-
miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3
-
Liu LH, Li H, Li JP, et al: miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Biochem Biophys Res Commun 416: 31-38, 2011.
-
(2011)
Biochem Biophys Res Commun
, vol.416
, pp. 31-38
-
-
Liu, L.H.1
Li, H.2
Li, J.P.3
-
23
-
-
78149320174
-
microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2
-
Zhang H, Cai X, Wang Y, Tang H, Tong D and Ji F: microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24: 1363-1369, 2010.
-
(2010)
Oncol Rep
, vol.24
, pp. 1363-1369
-
-
Zhang, H.1
Cai, X.2
Wang, Y.3
Tang, H.4
Tong, D.5
Ji, F.6
-
24
-
-
80755184684
-
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma
-
Thayanithy V, Sarver AL, Kartha RV, et al: Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone 50: 171-181, 2012.
-
(2012)
Bone
, vol.50
, pp. 171-181
-
-
Thayanithy, V.1
Sarver, A.L.2
Kartha, R.V.3
-
25
-
-
14844354250
-
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
-
Eis PS, Tam W, Sun L, et al: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632, 2005.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 3627-3632
-
-
Eis, P.S.1
Tam, W.2
Sun, L.3
-
26
-
-
26044481464
-
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
-
Kluiver J, Poppema S, de Jong D, et al: BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-249, 2005.
-
(2005)
J Pathol
, vol.207
, pp. 243-249
-
-
Kluiver, J.1
Poppema, S.2
de Jong, D.3
-
27
-
-
0031022801
-
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group
-
Provisor AJ, Ettinger LJ, Nachman JB, et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15: 76-84, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 76-84
-
-
Provisor, A.J.1
Ettinger, L.J.2
Nachman, J.B.3
-
28
-
-
0038518570
-
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651
-
Goorin AM, Schwartzentruber DJ, Devidas M, et al; Pediatric Oncology Group: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21: 1574-1580, 2003.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1574-1580
-
-
Goorin, A.M.1
Schwartzentruber, D.J.2
Devidas, M.3
-
29
-
-
84885900540
-
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
-
Lauvrak SU, Munthe E, Kresse SH, et al: Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer 109: 2228-2236, 2013.
-
(2013)
Br J Cancer
, vol.109
, pp. 2228-2236
-
-
Lauvrak, S.U.1
Munthe, E.2
Kresse, S.H.3
-
30
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
-
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
31
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
33
-
-
0027082303
-
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup
-
Bramwell VH, Burgers M, Sneath R, et al: A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 10: 1579-1591, 1992.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1579-1591
-
-
Bramwell, V.H.1
Burgers, M.2
Sneath, R.3
-
34
-
-
0027381042
-
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin
-
Bacci G, Picci P, Ferrari S, et al: Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72: 3227-3238, 1993.
-
(1993)
Cancer
, vol.72
, pp. 3227-3238
-
-
Bacci, G.1
Picci, P.2
Ferrari, S.3
-
35
-
-
70349808172
-
Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel
-
Mora J, Cruz CO, Parareda A and de Torres C: Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. J Pediatr Hematol Oncol 31: 723-729, 2009.
-
(2009)
J Pediatr Hematol Oncol
, vol.31
, pp. 723-729
-
-
Mora, J.1
Cruz, C.O.2
Parareda, A.3
de Torres, C.4
-
36
-
-
10844236347
-
A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma
-
McTiernan A and Whelan JS: A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma 8: 71-76, 2004.
-
(2004)
Sarcoma
, vol.8
, pp. 71-76
-
-
McTiernan, A.1
Whelan, J.S.2
-
37
-
-
48249154929
-
Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma
-
Navid F, Willert JR, McCarville MB, et al: Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer 113: 419-425, 2008.
-
(2008)
Cancer
, vol.113
, pp. 419-425
-
-
Navid, F.1
Willert, J.R.2
McCarville, M.B.3
-
38
-
-
0036847703
-
Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571
-
McGary EC, Weber K, Mills L, et al: Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8: 3584-3591, 2002.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3584-3591
-
-
McGary, E.C.1
Weber, K.2
Mills, L.3
-
39
-
-
0037258254
-
Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma
-
Sulzbacher I, Birner P, Trieb K, Traxler M, Lang S and Chott A: Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma. Mod Pathol 16: 66-71, 2003.
-
(2003)
Mod Pathol
, vol.16
, pp. 66-71
-
-
Sulzbacher, I.1
Birner, P.2
Trieb, K.3
Traxler, M.4
Lang, S.5
Chott, A.6
-
40
-
-
43049095679
-
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
-
Kubo T, Piperdi S, Rosenblum J, et al: Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Cancer 112: 2119-2129, 2008.
-
(2008)
Cancer
, vol.112
, pp. 2119-2129
-
-
Kubo, T.1
Piperdi, S.2
Rosenblum, J.3
-
41
-
-
18844467502
-
Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
-
Kaya M, Wada T, Akatsuka T, et al: Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6: 572-577, 2000.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 572-577
-
-
Kaya, M.1
Wada, T.2
Akatsuka, T.3
-
42
-
-
77953256426
-
R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts
-
Kolb EA, Kamara D, Zhang W, et al: R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts. Pediatr Blood Cancer 55: 67-75, 2010.
-
(2010)
Pediatr Blood Cancer
, vol.55
, pp. 67-75
-
-
Kolb, E.A.1
Kamara, D.2
Zhang, W.3
-
43
-
-
74549164751
-
NVP-BEZ235 as a new therapeutic option for sarcomas
-
Manara MC, Nicoletti G, Zambelli D, et al: NVP-BEZ235 as a new therapeutic option for sarcomas. Clin Cancer Res 16: 530-540, 2010.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 530-540
-
-
Manara, M.C.1
Nicoletti, G.2
Zambelli, D.3
-
44
-
-
74549210540
-
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
-
Pignochino Y, Grignani G, Cavalloni G, et al: Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. Mol Cancer 8: 118, 2009.
-
(2009)
Mol Cancer
, vol.8
, pp. 118
-
-
Pignochino, Y.1
Grignani, G.2
Cavalloni, G.3
-
45
-
-
84866457087
-
The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression
-
Zhang W, Qian JX, Yi HL, et al: The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression. Mol Biol (Mosk) 46: 622-627, 2012.
-
(2012)
Mol Biol (Mosk)
, vol.46
, pp. 622-627
-
-
Zhang, W.1
Qian, J.X.2
Yi, H.L.3
|